Enantiomeric enrichment and stereoselective synthesis of chiral amines
CA 2018773 C · Owner: Celgene Corporation · Inventors: Matcham, George W.; Stirling, David I.; Zeitlin, Andrew L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Amines in which the amino group is on a secondary carbon atom which is chirally substituted can be enantiomerically enriched by the action of an omega-amino acid transaminase which has the property of preferentially converting one of the two chiral forms to a ketone. The process also can be used to stereoselectively synthesize one chiral form from ketones substantially to the exclusion of the other.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 12, 1990 and granted March 21, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 12, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 12, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.